Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Leukemia, Published online: 24 February 2020; doi:10.1038/s41375-020-0770-8Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Source: Leukemia - February 23, 2020 Category: Hematology Authors: Franco Locatelli James A. Whitlock Christina Peters Christiane Chen-Santel Victoria Chia Robyn M. Dennis Kenneth M. Heym Aaron J. Katz Michael A. Kelsh Richard Sposto Huakang Tu Catherine A. Tuglus Anupam Verma Luciana Vinti Jennifer J. Wilkes Nathalya Zu Source Type: research